• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • CR Radio
        • CR Radio
        • Protagonistas de Fe
  • News Tips
  • Subscribe
Mifepristone, the first medication in a two-drug regimen used for early abortion and more recently for early miscarriage care, is prepared for a patient at Alamo Women's Clinic in Carbondale, Ill., April 20, 2023. Representatives of Walgreens and CVS announced March 1 their pharmacies will begin dispensing mifepristone in select states where both abortion and pharmacy distribution of the drug is legal. (OSV News photo/Evelyn Hockstein, Reuters)

Walgreens, CVS pharmacies to begin dispensing pills used for abortion, early miscarriage

March 2, 2024
By Gina Christian
OSV News
Filed Under: Feature, News, Respect Life, World News

Two major U.S. pharmacy chains have announced they will begin dispensing the drug mifepristone, which has been prescribed for both abortion and early miscarriage, within the coming days.

Representatives of Walgreens and CVS announced the move March 1 in an interview with The New York Times.

Walgreens also issued a press release the same day, stating that it “expects to begin dispensing within a week, consistent with federal and state laws” in a “phased rollout in select locations to allow us to ensure quality, safety, and privacy for our patients, providers, and team members.”

Both pharmacy chains have received certification from the U.S. Food and Drug Administration to supply the drug under guidelines the agency issued last year. At present, the chains will only provide mifepristone in person, not by mail, in select states where both abortion and pharmacy distribution of abortion drugs is legal.

A synthetic steroid, mifepristone — introduced 20 years ago — works by blocking the hormone progesterone, which is necessary for pregnancy to continue. When used in combination with misoprostol, which causes contractions, it induces a “medication abortion” up to 10 weeks into a pregnancy. This regimen is now used for more than half of U.S. abortions, according to the abortion research firm Guttmacher Institute.

However, the same pills are also now prescribed to women who experience early pregnancy miscarriage in order to expel any fetal remains and residual pregnancy tissue from the womb. While misoprostol has been prescribed alone by OB-GYNs, the American College of Obstetricians and Gynecologists recently updated its protocols to recommend a combination of mifepristone and misoprostol as more effective than misoprostol alone for early miscarriage care based on research published since 2018.

According to the National Library of Medicine, an estimated 26 percent of all pregnancies, and up to 10 percent of clinically recognized pregnancies, end in miscarriage, the loss of pregnancy less than 20-weeks gestation.

Because the Catholic Church teaches that all human life is sacred and must be respected from conception to natural death, it opposes the use of medicine when it is intended to cause direct abortion, which takes the life of the unborn child. However, the church also does not oppose the use of medicine when it is intended for restoring the body to health or life, which it calls “precious gifts entrusted to us by God.”

Walgreens plans to offer the mifepristone in select pharmacies in California, Illinois, Massachusetts, New York and Pennsylvania, while CVS will distribute the drug in all of its Massachusetts and Rhode Island pharmacies.

In a March 1 statement, President Joe Biden called the pharmacy chains’ announcement “an important milestone in ensuring access to mifepristone,” and encouraged “all pharmacies that want to pursue this option to seek (FDA) certification” to do so.

However, in a press release issued the same day, Susan B. Anthony Pro-Life America lambasted the move, citing mifepristone’s longstanding, morally illicit usage for early abortion.

“As two of the world’s largest, most trusted ‘health’ brands, the decision by CVS and Walgreens to sell dangerous abortion drugs is shameful, and the harm to unborn babies and their mothers incalculable,” Kate Daniel, SBA Pro-Life America’s state policy director, said.

Daniel accused the Biden administration of “pushing to turn every pharmacy and post office in America into an abortion center for the sake of abortion industry greed,” claiming the FDA under Democratic presidents has “illegally rolled back basic safety standards, like in-person doctor visits, even allowing these deadly drugs to be sent through the mail.”

Daniel noted the Supreme Court will hear oral arguments March 26 for FDA v. Alliance for Hippocratic Medicine and Danco v. Alliance for Hippocratic Medicine, which involve legal challenges to the FDA’s regulatory approval of mifepristone.

Read More Respect Life

Catholic governor signs historic personhood law for the unborn in Puerto Rico

2025 spans life spectrum, from abortion and family programs to immigration and death penalty

HHS proposes new regulatory actions to prohibit gender transition procedures for minors

Approximately 50 Planned Parenthood clinics closed in 2025, report says

Tennessee faith leaders urge governor to stop all executions

Illinois Catholic bishops back pregnancy centers’ suit over law requiring abortion referrals

Copyright © 2024 OSV News

Print Print

Primary Sidebar

Gina Christian

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • Archbishop Lori announces clergy appointments, including associate pastor and special ministry

  • Question Corner: Why is New Year’s Day a holy day of obligation?

  • Son of Catholic influencer, prayed for by thousands, dies

  • The bucket list 

  • The sun rises over the ocean Today could have been the day

| Latest Local News |

Comboni Missionary Sister Andre Rothschild, who ministered at St. Matthew, dies at 79

Radio Interview: Carrying grace into the new year

Westernport experiences a flood of relief 

Archbishop Lori announces clergy appointments, including associate pastor and special ministry

Most popular stories and commentaries of 2025 on CatholicReview.org

| Latest World News |

As jubilee year ends, the faithful heed Pope Leo’s call to keep the church alive

Pope Leo’s first Extraordinary Consistory: What to expect?

Christians must resist allure of power, serve humanity, pope says at end of Holy Year

As Maduro faces New York trial, uncertainty lingers for Venezuelan migrants

New Orleans archbishop apologizes to abuse survivors as settlement takes effect

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • As jubilee year ends, the faithful heed Pope Leo’s call to keep the church alive
  • Pope Leo’s first Extraordinary Consistory: What to expect?
  • Comboni Missionary Sister Andre Rothschild, who ministered at St. Matthew, dies at 79
  • Christians must resist allure of power, serve humanity, pope says at end of Holy Year
  • As Maduro faces New York trial, uncertainty lingers for Venezuelan migrants
  • New Orleans archbishop apologizes to abuse survivors as settlement takes effect
  • Son of Catholic influencer, prayed for by thousands, dies
  • Vatican sees record number of visitors during Jubilee year, officials say
  • Sisters who manage school of kidnapped Nigerian children: ‘Your compassion became a lifeline’

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2026 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED